Inflammation and fatigue dimensions in advanced cancer patients and cancer survivors: An explorative study

Cancer

Volumn 118, Issue 23, 2012, Pages 6005-6011

  De Raaf, Pleun J ^a   Sleijfer, Stefan ^a   Lamers, Cor H J ^a   Jager, Agnes ^a   Gratama, Jan Willem ^a   Van Der Rijt, Carin C D ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

C reactive protein; fatigue; interleukin 1 receptor antagonist protein; interleukin 6; interleukin 8; mental fatigue; neoplasms; neopterin; palliative care; survivors

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; INTERLEUKIN 8; NEOPTERIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER FATIGUE; CANCER PATIENT; CANCER SURVIVOR; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; DYSTHYMIA; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; FATIGUE; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; NEOPLASMS; SURVIVORS;

EID: 84869490658     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.27613     Document Type: Article

References (30)

1. Hofman M, Ryan JL, Figueroa-Moseley CD, Jean-Pierre P, Morrow GR,. Cancer-related fatigue: the scale of the problem. Oncologist. 2007; 12 (suppl 1): 4-10.
2. Glaus A, Crow R, Hammond S,. A qualitative study to explore the concept of fatigue/tiredness in cancer patients and in healthy individuals. Support Care Cancer. 1996; 4: 82-96. (Pubitemid 126469092)
3. Ryan JL, Carroll JK, Ryan EP, Mustian KM, Fiscella K, Morrow GR,. Mechanisms of cancer-related fatigue. Oncologist. 2007; 12 (suppl 1): 22-34.
4. Jager A, Sleijfer S, van der Rijt CC,. The pathogenesis of cancer related fatigue: could increased activity of pro-inflammatory cytokines be the common denominator? Eur J Cancer. 2008; 44: 175-181.
5. Schubert C, Hong S, Natarajan L, Mills PJ, Dimsdale JE,. The association between fatigue and inflammatory marker levels in cancer patients: a quantitative review. Brain Behav Immun. 2007; 21: 413-427. (Pubitemid 46528677)
6. Seruga B, Zhang H, Bernstein LJ, Tannock IF,. Cytokines and their relationship to the symptoms and outcome of cancer. Nat Rev Cancer. 2008; 8: 887-899.
7. de Raaf PJ, de Klerk C, Timman R, Hinz A, van der Rijt CCD,. Differences in fatigue experiences between advanced cancer patients, cancer survivors and the general population. J Pain Symptom Manage. 2012;doi: 10.1016/j.jpainsymman. 2011.12.279.
8. Lange T, Dimitrov S, Born J,. Effects of sleep and circadian rhythm on the human immune system. Ann N Y Acad Sci. 2010; 1193: 48-59.
9. Smets EM, Garssen B, Bonke B, De Haes JC,. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res. 1995; 39: 315-325.
10. Schwarz R, Krauss O, Hinz A,. Fatigue in the general population. Onkologie. 2003; 26: 140-144. (Pubitemid 36677078)
11. Inagaki M, Isono M, Okuyama T, et al. Plasma interleukin-6 and fatigue in terminally ill cancer patients. J Pain Symptom Manage. 2008; 35: 153-161.
12. Laird BJ, Scott AC, Colvin LA, et al. Pain, depression, and fatigue as a symptom cluster in advanced cancer. J Pain Symptom Manage. 2011; 42: 1-11.
13. Mantovani G, Maccio A, Madeddu C, et al. A phase 2 study with antioxidants, both in the diet and supplemented, pharmaconutritional support, progestagen, and anti-cyclooxygenase-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia and oxidative stress. Cancer Epidemiol Biomarkers Prev. 2006; 15: 1030-1034. (Pubitemid 43823535)
14. Rich T, Innominato PF, Boerner J, et al. Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancer. Clin Cancer Res. 2005; 11: 1757-1764. (Pubitemid 40471837)
15. Gabay C, Kushner I,. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999; 340: 448-454. (Pubitemid 29084777)
16. Dinarello CA,. Biologic basis for interleukin-1 in disease. Blood. 1996; 87: 2095-2147. (Pubitemid 26086851)
17. Gabay C, Smith MF, Eidlen D, Arend WP,. Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein. J Clin Invest. 1997; 99: 2930-2940. (Pubitemid 27278670)
18. El-Osta H, Janku F, Kurzrock R,. Successful treatment of Castleman's disease with interleukin-1 receptor antagonist (Anakinra). Mol Cancer Ther. 2010; 9: 1485-1488.
19. Nishimoto N, Kanakura Y, Aozasa K, et al. Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease. Blood. 2005; 106: 2627-2632. (Pubitemid 41510733)
20. Bayliss TJ, Smith JT, Schuster M, Dragnev KH, Rigas JR,. A humanized anti-IL-6 antibody (ALD518) in non-small cell lung cancer. Expert Opin Biol Ther. 2011; 11: 1663-1668.
21. Bower JE, Ganz PA, Aziz N, Fahey JL,. Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosom Med. 2002; 64: 604-611. (Pubitemid 34791163)
22. Collado-Hidalgo A, Bower JE, Ganz PA, Cole SW, Irwin MR,. Inflammatory biomarkers for persistent fatigue in breast cancer survivors. Clin Cancer Res. 2006; 12: 2759-2766.
23. Dimeo F, Schmittel A, Fietz T, et al. Physical performance, depression, immune status and fatigue in patients with hematological malignancies after treatment. Ann Oncol. 2004; 15: 1237-1242. (Pubitemid 39199311)
24. Knobel H, Loge JH, Nordoy T, et al. High level of fatigue in lymphoma patients treated with high dose therapy. J Pain Symptom Manage. 2000; 19: 446-456. (Pubitemid 30447370)
25. Orre IJ, Murison R, Dahl AA, Ueland T, Aukrust P, Fossa SD,. Levels of circulating interleukin-1 receptor antagonist and C-reactive protein in long-term survivors of testicular cancer with chronic cancer-related fatigue. Brain Behav Immun. 2009; 23: 868-874.
26. Orre IJ, Reinertsen KV, Aukrust P, et al. Higher levels of fatigue are associated with higher CRP levels in disease-free breast cancer survivors. J Psychosom Res. 2011; 71: 136-141.
27. Munch TN, Strömgren AS, Pedersen L, Petersen MA, Hoermann L, Groenvold M,. Multidimensional measurement of fatigue in advanced cancer patients in palliative care: an application of the multidimensional fatigue inventory. J Pain Symptom Manage. 2006; 31: 533-541. (Pubitemid 43949120)
28. Kuhnt S, Ernst J, Singer S, et al. Fatigue in cancer survivors-prevalence and correlates. Onkologie. 2009; 32: 312-317.
29. Miller AH, Ancoli-Israel S, Bower JE, Capuron L, Irwin MR,. Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. J Clin Oncol. 2008; 26: 971-982. (Pubitemid 351409339)
30. Bower JE, Ganz PA, Irwin MR, Kwan L, Breen EC, Cole SW,. Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism? J Clin Oncol. 2011; 29: 3517-3522.